Résultats de la recherche - Hanyun Ren
- Résultat(s) 1 - 8 résultats de 8
-
1
-
2
Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational St... par Yu‐Qian Sun, Fan‐Yi Meng, Mingzhe Han, Xi Zhang, Li Yu, He Huang, Depei Wu, Hanyun Ren, Chun Wang, Zhi-Xiang Shen, Yu Ji, Xiao‐Jun Huang
Publié 2015Artigo -
3
Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor par Yujun Dong, Mingyue Wang, Lin Nong, Lihong Wang, Xinan Cen, Wei Liu, Sainan Zhu, Yu-Hua Sun, Zeyin Liang, Yuan Li, Jin-Ping Ou, Zhi-Xiang Qiu, Hanyun Ren
Publié 2015Artigo -
4
Myeloablative Haploidentical Transplant as an Alternative to Matched Sibling Transplant for Peripheral T-Cell Lymphomas par Zhenyang, Gu, Nainong, Li, Xiaoxiong, Wu, Maihong, Wang, Xiaorui, Fu, Zhao, Wang, Hanyun, Ren, Yuhang, Li, Xiaofan, Li, Yamei, Wu, Yao, Liu, Mingzhi, Zhang, Yini, Wang, Daihong, Liu, Yujun, Dong, Liangding, Hu, Wenrong, Huang
Publié 2021Texte -
5
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from th... par Lan‐Ping Xu, Chen Hu, Jing Chen, Mingzhe Han, He Huang, Yongrong Lai, Dai‐Hong Liu, Qifa Liu, Ting Liu, Ming Jiang, Hanyun Ren, Yongping Song, Zimin Sun, Jianmin Wang, Depei Wu, Daobin Zhou, Ping Zou, Kai‐Yan Liu, Xiao‐Jun Huang
Publié 2018Revisão -
6
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update par Xiaohui Zhang, Jing Chen, Mingzhe Han, He Huang, Erlie Jiang, Ming Jiang, Yongrong Lai, Dai‐Hong Liu, Qifa Liu, Ting Liu, Hanyun Ren, Yongping Song, Zimin Sun, Xiaowen Tang, Jianmin Wang, Depei Wu, Lan‐Ping Xu, Xi Zhang, Daobin Zhou, Xiao‐Jun Huang
Publié 2021Artigo -
7
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study par Xiao‐Jun Huang, Lugui Qiu, Jie Jin, Daobin Zhou, Xiequn Chen, Ming Hou, Jianda Hu, Yu Hu, Xiaoyan Ke, Junmin Li, Yingmin Liang, Ting Liu, Yue Lv, Hanyun Ren, Aining Sun, Jianmin Wang, Chunting Zhao, Mariya Salman, Steven Sun, Angela Howes, Jingzhao Wang, Peng Wu, Jianyong Li
Publié 2018Artigo -
8
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study par Ying‐Jun Chang, Depei Wu, Yongrong Lai, Qifa Liu, Yu‐Qian Sun, Jiong Hu, Yu Hu, Jianfeng Zhou, Juan Li, Shunqing Wang, Wei Li, Xin Du, Dongjun Lin, Hanyun Ren, Chen Fang-pin, Yuhua Li, Xi Zhang, He Huang, Yongping Song, Ming Jiang, Jianda Hu, Yingmin Liang, Jingbo Wang, Yang Xiao, Xiao‐Jun Huang
Publié 2020Artigo
Outils de recherche:
Sujets similaires
Medicine
Internal medicine
Transplantation
Biology
Gastroenterology
Genetics
Hematopoietic stem cell transplantation
Immunology
Oncology
Stem cell
Confidence interval
Cumulative incidence
Hazard ratio
Hematology
Incidence (geometry)
Intensive care medicine
Leukemia
Optics
Pathology
Physics
Randomized controlled trial
Surgery
Absolute neutrophil count
Adverse effect
Antibody
Artificial intelligence
Autoantibody
Bone marrow
Cell biology
Chemotherapy